"0597-0385-86" National Drug Code (NDC)

Trijardy Xr 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-86)
(Boehringer Ingelheim Pharmaceuticals, Inc.)

NDC Code0597-0385-86
Package Description180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-86)
Product NDC0597-0385
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameTrijardy Xr
Non-Proprietary NameEmpagliflozin, Linagliptin, Metformin Hydrochloride
Dosage FormTABLET, EXTENDED RELEASE
UsageORAL
Start Marketing Date20200423
Marketing Category NameNDA
Application NumberNDA212614
ManufacturerBoehringer Ingelheim Pharmaceuticals, Inc.
Substance NameEMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Strength12.5; 2.5; 1000
Strength Unitmg/1; mg/1; mg/1
Pharmacy ClassesBiguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/0597-0385-86